University of California San Francisco

Chiung-Yu Huang large headshot
Chiung-Yu
Huang
PhD, MS

Professor
Department of Epidemiology & Biostatistics 

Address

550 16th Street, #2534
San Francisco, CA 94158
United States

    Education

    Institution Degree Dept or School End Date
    Johns Hopkins University Adjunct Professor 2018
    University of California Professor 2017
    Johns Hopkins University Associate Professor 2013
    National Institute of Allergy and Infectious Diseases, NIH Mathematical Statistician 2004
    Johns Hopkins University PhD Biostatistics 2002
    University of Minnesota Assistant Professor 2002
    National Tsing-Hua University MS Mathematics 1996
    National Tsing-Hua University BS Mathematics 1994

    Awards & Honors

    Award Conferred By Date
    Elected Fellow Institute of Mathematical Statistics 2025
    Y.S. Chow Distinguished Lecture Award Chinese Institute of Probability and Statistics 2022
    Elected Fellow American Statistical Association 2018
    Distinguished Alumni Award National Tainan Girls' Senior High School, Tainan, Taiwan 2017
    NIH Merit Award National Institute of Allergy and Infectious Diseases, Bethesda, MD 2007
    Margaret Merrell Award Department of Biostatistics, Johns Hopkins University, Baltimore, MD 2002

    Program Affiliations

    World Health Organization

    Cameroon’s Ministry of Health

    Center for Global Surgical Studies

    Grants and Funding

    • Improving causal inference in Alzheimer's Disease prevention research on modifiable risk factors: the Triangulation of Innovative Methods to End AD (TIME-AD) project | NIH/NIA | 2024-09-01 - 2029-08-31 | Role: Co-lead of Analytics Core
    • Cancer Center Support Grant – Biostatistics & Population Research Shared Resource | NIH/NCI | 2023-09-01 - 2028-05-31 | Role: Co-Investigator
    • The impact of body composition on peri-operative and patient-centered outcomes in lung transplantation | NIH/NHLBI | 2022-08-01 - 2027-07-31 | Role: Co-Investigator
    • CF Statistical Expertise and Network (CF StatNet) Award | Cystic Fibrosis Foundation | 2022-09-01 - 2025-08-31 | Role: Statistician
    • Mixed Data Meta-analysis: Integration of Individual Participant and Aggregate Data | PCORI | 2021-11-01 - 2025-01-31 | Role: Co-Investigator
    • Predicting post-transplant mortality and global functional health based on pre-transplant functional status in liver transplantation | NIH | 2018-06-15 - 2023-05-31 | Role: Co-Investigator
    • UCSF Liver Core Center, Biostatistics Core | NIH/NIDDK | 2018-06-01 - 2023-05-31 | Role: Statistician
    • Cancer Center Support Grant | NIH | 1999-08-05 - 2023-05-31 | Role: Co-Investigator
    • Allergy, Immunology and Transplantation Research (UCSF Coordinating Center) | NIH/NIAID | 2021-09-01 - 2023-01-31 | Role: Statistician
    • A novel natural history study of medullary thyroid carcinoma | University of Texas M.D. Anderson Cancer Center | 2019-09-01 - 2022-07-31 | Role: Statistician
    • Statistical Methods for Survival and Recurrent Event Data in Clinical Research | NIH | 2015-07-01 - 2021-06-30 | Role: Principal Investigator
    • Reprogramming the pancreatic tumor microenvironment with immunotherapy | NIH/NCI | 2015-07-01 - 2020-06-30 | Role: Statistician/Principal Investigator (Subaward)
    • Comparing Patient Centered Outcomes in the Management of Pain between Emergency Departments and Dedicated Acute Care Facilities for Adults with Sickle Cell disease | PCORI | 2017-09-01 - 2018-12-31 | Role: Statistician/Principal Investigator (Subaward)

    Research Interests

    Violence and Injury Prevention

    Management of Health Services

    Strengthening Health Systems

    Positioning Injury Prevention as a Priority Area in the National Health Agenda

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 185
    1. Triangulating Evidence to Infer Pathways that Influence Ebola Virus Disease-Related Stigma and Clinical Findings among Survivors: An Observational Cohort Study.
      Kelly JD, Badio M, Drew C, Wilson B, Cooper JB, Glayweon M, Johnson K, Moses JS, Gayedu-Dennis D, Torres JM, Oldenburg CE, Davidson MC, Huang CY, Steward WT, Sneller MC, Rutherford GW, Reilly C, Fallah MP, Weiser SD| | PubMed
    2. Construct and Predictive Validity of Sarcopenia in Lung Transplant Candidates.
      Maheshwari JA, Kolaitis NA, Anderson MR, Benvenuto L, Gao Y, Katz PP, Greenland J, Wolters PJ, Covinsky K, Hays SR, Kukreja J, Calabrese DR, Venado A, Shah RJ, Leard LE, Trinh B, Huang CY, Glidden D, Kleinhenz ME, Golden JA, Sutter N, Tietje-Ulrich G, Criner RN, Arcasoy SM, Christie JD, Diamond J, Singer JP| | PubMed
    3. Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study.
      Moksud N, Loo LWM, Yang J, Huang CY, Haiman CA, Le Marchand L, Wilkens LR, Cheng I| | PubMed
    4. Additive rates model for recurrent event data with intermittently observed time-dependent covariates.
      Lyu T, Luo X, Huang CY, Sun Y| | PubMed
    5. Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study.
      Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Abu Al Hamayel N, Huang CY, Segal JB, Varadhan R| | PubMed
    6. Accuracy of the Lymph Node Yield in Surgery for Papillary Thyroid Cancer in Children.
      Yap A, Shui A, Gosnell J, Huang CY, Sosa JA, Roman S| | PubMed
    7. Synthesizing external aggregated information in the penalized Cox regression under population heterogeneity.
      Sheng Y, Sun Y, Huang CY, Kim MO| | PubMed
    8. Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer.
      Connolly RM, Leal JP, Solnes L, Huang CY, Carpenter A, Gaffney K, Abramson V, Carey LA, Liu MC, Rimawi M, Specht J, Storniolo AM, Valero V, Vaklavas C, Krop IE, Winer EP, Camp M, Miller RS, Wolff AC, Cimino-Mathews A, Park BH, Wahl RL, Stearns V| | PubMed
    9. Phase 1b trial of isatuximab, an anti-CD38 monoclonal antibody, in combination with carfilzomib as treatment of relapsed/refractory multiple myeloma.
      Martin TG, Shah N, Richter J, Vesole DH, Wong SW, Huang CY, Madduri D, Jagannath S, Siegel DS, Biran N, Wolf JL, Parekh S, Cho HJ, Munster P, Richard S, Ziti-Ljajic S, Chari A| | PubMed
    10. Early Time-to-Tocilizumab after B Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy in Myeloma.
      Banerjee R, Marsal J, Huang CY, Lo M, Thiruvengadam SK, Kennedy VE, Arora S, Wolf JL, Martin TG, Wong SW, Shah N| | PubMed